Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

SummaryWe analysed the involvement of known and putative tumour suppressor- and oncogene loci in ductal carcinoma in situ (DCIS) by microsatellite analysis (LOH), Southern blotting and comparative genomic hybridization (CGH). A total of 78 pure DCIS cases, classified histologically as well, intermediately and poorly differentiated, were examined for LOH with 76 markers dispersed along all chromosome arms. LOH on chromosome 17 was more frequent in poorly differentiated DCIS (70%) compared to well-differentiated DCIS (17%), whereas loss on chromosome 16 was associated with well- and intermediately differentiated DCIS (66%). For a subset we have done Southern blot- and CGH analysis. C-erbB2/neu was amplified in 30% of poorly differentiated DCIS. No amplification was found of c-myc, mdm2, bek, flg and the epidermal growth factor (EGF)-receptor. By CGH, most frequent alterations in poorly differentiated DCIS were gains on 8q and 17q22–24 and deletion on 17p, whereas in well-differentiated DCIS amplification on chromosome 1q and deletion on 16q were found. In conclusion, our data indicates that inactivation of a yet unknown tumour suppressor gene on chromosome 16q is implicated in the development of most well and intermediately differentiated DCIS whereas amplification and inactivation of various genes on chromosome 17 are implicated in the development of poorly differentiated DCIS. Furthermore these data show that there is a genetic basis for the classification of DCIS in a well and poorly differentiated type and support the evidence of different genetic routes to develop a specific type of carcinoma in situ of the breast.

• Publication year

  1999

• Venue

  British Journal of Cancer

• Publication date

  1999-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.bjc.6693372PMID 10604741PMCID 2362977
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TP53 alterations in atypical ductal hyperplasia and ductal carcinomain situ of the breast

  2005cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.

  1998cited by this paper
• Amplification units and translocation at chromosome 17q and c-erbB2 overexpression in the pathogenesis of breast cancer

  1998cited by this paper
• Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.

  1997cited by this paper
• Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.

  1997cited by this paper
• High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination.

  1997cited by this paper
• Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.

  1997cited by this paper
• Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast.

  1997cited by this paper
• Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma

  1997cited by this paper
• Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer

  1997cited by this paper
• Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.

  1996cited by this paper
• Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.

  1996cited by this paper
• E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.

  1996cited by this paper
• Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast.

  1996cited by this paper
• E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.

  1995cited by this paper
• Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.

  1995cited by this paper
• Prognostic classification of breast ductal carcinoma-in-situ.

  1995cited by this paper
• Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.

  1995cited by this paper
• mdm2 gene alterations and mdm2 protein expression in breast carcinomas

  1995cited by this paper
• Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas.

  1995cited by this paper
• Somatic genetic changes in human breast cancer.

  1994cited by this paper
• Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.

  1994cited by this paper
• Ductal carcinoma in situ: a proposal for a new classification.

  1994cited by this paper
• Point Mutation of the E–Cadherin Gene in Invasive Lobular Carcinoma of the Breast

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples.

  1994cited by this paper
• Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

  1994cited by this paper
• Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity.

  1994cited by this paper
• At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer

  1994cited by this paper
• The classification of ductal carcinoma in situ and its association with biological markers.

  1994cited by this paper
• Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

  1992cited by this paper
• Pathology of The Breast

  1992cited by this paper
• c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

  1992cited by this paper
• Amplification of a gene encoding a p53-associated protein in human sarcomas

  1992cited by this paper
• Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

  1992cited by this paper
• BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.

  1991cited by this paper
• Genetic Alterations During Colorectal-Tumor Development

  1989cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.

  1987cited by this paper
• Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor

  1986cited by this paper
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

  1985cited by this paper
• Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

  1984cited by this paper
• [Pathology of the breast].

  1954cited by this paper
• © 1997 Cancer Research Campaign

  year unknowncited by this paper

• Germline variant affecting p53β isoforms predisposes to familial cancer

  2024cites this paper
• Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia

  2021cites this paper
• Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma

  2019cites this paper
• Breast Cancer Screening

  2018cites this paper
• Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification

  2018cites this paper
• Multicolor immunofluorescence reveals that p63- and/or K5-positive progenitor cells contribute to normal breast epithelium and usual ductal hyperplasia but not to low-grade intraepithelial neoplasia of the breast

  2017cites this paper
• Overdiagnosis in the Dutch and Norwegian breast cancer screening program

  2016cites this paper
• Easily recognizable sonographic patterns of ductal carcinoma in situ of the breast

  2016cites this paper
• Biomarkers in ductal carcinoma in situ

  2016cites this paper
• Ductal carcinoma in situ – update on risk assessment and management

  2016cites this paper
• The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening

  2016cites this paper
• Copy number analysis of ductal carcinoma in situ with and without recurrence

  2015cites this paper
• Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast

  2015influential citation
• Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis

  2015cites this paper
• Scribble Modulates the MAPK/Fra1 Pathway to Disrupt Luminal and Ductal Integrity and Suppress Tumour Formation in the Mammary Gland

  2014cites this paper
• THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data

  2013cites this paper
• Karzinogenese der Mammakarzinome

  2013cites this paper
• Dual-Color Fluorescence In Situ Hybridization Reveals an Association of Chromosome 8q22 but Not 8p21 Imbalance with High Grade Invasive Breast Carcinoma

  2013cites this paper
• Chromosome 16q loss--a genetic key to the understanding of breast carcinogenesis.

  2013cites this paper
• FGFR1 is amplified during the progression of in situ to invasive breast carcinoma

  2012cites this paper
• Is there ‘progression through grade’ in ductal invasive breast cancer?

  2012cites this paper
• Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesions

  2012cites this paper
• Analysis of gene expression alterations in premalignant progression from normal mammary epithelium to ductal carcinoma in situ by multiple orthogonal tools

  2012cites this paper
• Transitions Between Flat Epithelial Atypia and Low-grade Ductal Carcinoma In Situ of the Breast

  2012cites this paper
• Genomic alterations and phenotype of large compared to small high-grade ductal carcinoma in situ.

  2011cites this paper
• Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review.

  2011cites this paper
• Gene regulation by SMAR1: Role in cellular homeostasis and cancer.

  2011cites this paper
• Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor‐positive, invasive breast cancer

  2011cites this paper
• Molecular classification of breast carcinomas

  2010cites this paper
• Breast cancer progression is modulated by inherited genetic variance in multiple independent cohorts

  2010cites this paper
• Ductal carcinoma in situ: Current concepts

  2010cites this paper
• [Lobular intra-epithelial neoplasia: atypical lobular hyperplasia and lobular carcinoma in situ].

  2010cites this paper
• Cell Polarity in Motion: Redefining Mammary Tissue Organization Through EMT and Cell Polarity Transitions

  2010cites this paper
• Sonographic Findings of High‐Grade and Non–High‐Grade Ductal Carcinoma In Situ of the Breast

  2010cites this paper
• Néoplasies lobulaires intra-épithéliales : hyperplasie lobulaire atypique et cancer lobulaire in situ

  2010cites this paper
• Loss of MTG16a (CBFA2T3), a novel rDNA repressor, leads to increased ribogenesis and disruption of breast acinar morphogenesis

  2009cites this paper
• Functional analysis of CBFA2T3 : a breast cancer tumour suppressor from chromosome band 16q24.3.

  2009cites this paper
• Breast-conserving therapy for ductal carcinoma in situ Bijker

  2008cites this paper
• Gene expression profiling in breast cancer. A link between biology and clinical decision making

  2008cites this paper
• Chromosomal Alterations Associated with the Transition from In Situ to Invasive Breast Cancer

  2008cites this paper
• Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer

  2008cites this paper
• In situ and invasive lobular neoplasia of the breast

  2007cites this paper
• Chromogenic and fluorescent in situ hybridization in breast cancer.

  2007cites this paper
• Notch, Myc and Breast Cancer

  2007cites this paper
• Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data

  2007cites this paper
• The Phenotypic Spectrum of Basal-like Breast Cancers: A Critical Appraisal

  2007cites this paper
• Molecular and Morphologic Distinctions between Infiltrating Ductal and Lobular Carcinoma of the Breast

  2007cites this paper
• Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.

  2007cites this paper
• Correlation of Levels and Patterns of Genomic Instability With Histological Grading of DCIS

  2007cites this paper
• Genomic Instability and the Development of Metastatic Lymph Node Tumors

  2007cites this paper
• Chromosome 16 tumor‐suppressor genes in breast cancer

  2006cites this paper
• Classification of ductal carcinoma in situ by gene expression profiling

  2006influential citation
• The natural history of ductal carcinoma in situ of the breast: a review

  2006cites this paper
• Infrequent mutation of ATBF1 in human breast cancer

  2006cites this paper
• Radiobiology of breast cancer.

  2006cites this paper
• Basal-like breast cancer and the BRCA1 phenotype

  2006cites this paper
• Hormones and progeny of breast tumor cells

  2006cites this paper
• DCIS: Pathology and Molecular Markers

  2006cites this paper
• Classification of ductal carcinoma in situ by gene expression

  2006cites this paper
• Papillary lesions of the breast: a molecular progression?

  2005cites this paper
• Maintenance of Cell Type Diversification in the Human Breast

  2005cites this paper
• The origin of vimentin expression in invasive breast cancer: epithelial–mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?

  2005cites this paper
• Concordant loss of fragile gene expression early in breast cancer development

  2005cites this paper
• Functional identification of a BAC clone from 16q24 carrying a senescence gene SEN16 for breast cancer cells

  2005cites this paper
• Immunohistochemical and cytogenetic characterization of acantholytic squamous cell carcinoma of the breast

  2005cites this paper
• Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: Analysis of loss of heterozygosity

  2005cites this paper
• Biological variables and prognosis of DCIS.

  2005cites this paper
• Biological variables and prognosis of DCIS.

  2005cites this paper
• The molecular genetics of breast cancer: the contribution of comparative genomic hybridization.

  2005cites this paper
• Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry

  2004cites this paper
• Patterns of Chromosomal Alterations in Breast Ductal Carcinoma In situ

  2004cites this paper
• Different mechanisms of chromosome 16 loss of heterozygosity in well‐ versus poorly differentiated ductal breast cancer

  2004influential citation
• Expression of E2F‐4 in invasive breast carcinomas is associated with poor prognosis

  2004cites this paper
• Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites

  2004cites this paper
• Ductal carcinoma in situ: diagnosis and classification

  2004cites this paper
• Loss of heterozygosity at BRCA1, TP53, nm-23 and other loci on chromosome 17q in human breast carcinoma.

  2004cites this paper
• DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter

  2004cites this paper
• Pathology of high-risk breast lesions and ductal carcinoma in situ.

  2004cites this paper
• Molecular Evolutionary Patterns in Breast Cancer

  2003influential citation
• The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions

  2003cites this paper
• Molecular Biology In Cellular Pathology

  2003cites this paper
• Prevalence and prognostic value of c-erbB2 expression in non-small cell lung cancer (NSCLC).

  2003cites this paper
• Association of C‐MYC amplification with progression from the in situ to the invasive stage in C‐MYC‐amplified breast carcinomas

  2003influential citation
• Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.

  2003cites this paper
• The clinical management of ductal carcinoma in situ, lobular carcinoma in situ and atypical hyperplasia of the breast

  2003cites this paper
• Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast

  2003cites this paper
• Molecular alterations in sporadic breast cancer.

  2002cites this paper
• Loss of heterozygosity of chromosome 16q in gallbladder carcinoma.

  2002cites this paper
• Genetic pathways in the evolution of breast ductal carcinoma in situ

  2002cites this paper
• Cytogenetic Alterations and Cytokeratin Expression Patterns in Breast Cancer: Integrating a New Model of Breast Differentiation into Cytogenetic Pathways of Breast Carcinogenesis

  2002influential citation
• Anatomic Pathology / BREAST CANCERS AFTER BENIGN BIOPSY DIAGNOSES

  2002cites this paper
• C-myc oncogene amplification in ductal carcinoma in situ of the breast

  2002cites this paper
• CBFA 2 T 3 ( MTG 16 ) Is a Putative Breast Tumor Suppressor Gene from the Breast Cancer Loss of Heterozygosity Region at 16 q 24 . 31

  2002cites this paper
• Compilation of published comparative genomic hybridization studies.

  2002cites this paper
• Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas

  2002cites this paper
• Allelic loss in breast cancer.

  2002cites this paper
• Genetic Alterations in Presumptive Precursor Lesions of Breast Carcinomas

  2002cites this paper
• A working model for the time sequence of genetic changes in breast tumorigenesis.

  2002cites this paper
• CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.

  2002cites this paper
• Quantitative FISH analysis on interphase nuclei may improve diagnosis of DNA diploid breast cancers

  2002cites this paper